Table 2.

WHO/EORTC staging of MF/SS. Clinical stages and 5-year disease-free survival (DSS).

STAGE	T	N	M	B	5-Year DSS (%)
IA	1	0	0	0,1	98
IB	2	0	0	0,1	89
IIA	1,2	1,2	0	0,1	89
IIB	3	0–2	0	0,1	56
IIIA	4	0–2	0	0	54
IIIB	4	0–2	0	1	48
IVA1	1–4	0–2	0	2	41
IVA2	1–4	3	0	0–2	23
IVB	1–4	0–3	1	0–2	18